# 🎯 Manager's Ayesha Trial Matching Strategy

**Date:** January 28, 2025  
**Source:** Manager's strategy document  
**Goal:** Enhanced trial matching specifically for Ayesha's unique profile

---

## 👤 **AYESHA'S UNIQUE PROFILE**

| Feature | Value | Clinical Significance |
|---------|-------|---------------------|
| **MBD4** | p.K431Nfs54 (homozygous) | BER deficiency → PARP sensitive |
| **TP53** | Mutant-type (IHC) | Checkpoint bypass → Synthetic lethality |
| **PDGFRA** | p.S755P (VUS) | Potential TKI target |
| **PD-L1** | CPS 10 (positive) | Immunotherapy eligible |
| **Histology** | HGS Ovarian Stage IVB | Advanced, aggressive |
| **Germline** | MBD4-MANS syndrome | Hereditary cancer syndrome |

---

## 🔍 **ENHANCED SEARCH STRATEGY**

### **8 Targeted Searches (Instead of Generic "Ovarian Cancer")**

1. **MBD4/BER pathway trials**
   - Query: "MBD4 OR base excision repair OR BER deficiency"
   - Condition: "ovarian cancer"
   - Rationale: Direct match to her germline mutation

2. **Synthetic lethality trials (PARP)**
   - Query: "PARP inhibitor AND (platinum OR carboplatin)"
   - Condition: "high grade serous ovarian"
   - Rationale: BER + PARP = synthetic lethality

3. **TP53 mutation trials**
   - Query: "TP53 mutation OR p53 mutant"
   - Condition: "ovarian cancer"
   - Rationale: Her IHC shows mutant-type p53

4. **PD-L1 positive trials (CPS=10)**
   - Query: "pembrolizumab OR nivolumab OR PD-L1"
   - Condition: "ovarian cancer"
   - Status: "Recruiting"
   - Rationale: IO eligible with CPS ≥1

5. **DDR-deficient trials**
   - Query: "DNA damage repair OR DDR deficiency OR homologous recombination"
   - Condition: "ovarian cancer"
   - Rationale: MBD4 = DDR gene

6. **PARP + ATR/WEE1 combos**
   - Query: "(ceralasertib OR adavosertib OR ATR inhibitor OR WEE1) AND PARP"
   - Condition: "ovarian cancer"
   - Rationale: TP53 mutant → checkpoint bypass → ATR/WEE1 combos

7. **Hereditary cancer syndrome trials**
   - Query: "hereditary cancer syndrome OR germline mutation"
   - Condition: "ovarian cancer"
   - Rationale: MBD4-MANS syndrome

8. **PDGFRA trials (speculative)**
   - Query: "PDGFRA OR imatinib OR avapritinib"
   - Condition: "cancer" (broader search)
   - Rationale: If VUS resolves to pathogenic, TKI may be relevant

---

## 🏷️ **ENHANCED TAGGING**

### **Patient-Specific Relevance Scoring**

Add `ayesha_relevance_score` field to each trial:

```python
enhancements = {
    "mechanism_match": [],
    "eligibility_notes": [],
    "ayesha_relevance_score": 0.0
}

# MBD4/BER mentions: +0.3
# TP53 stratification: +0.2
# PARP target: +0.25
# PARP + ATR/WEE1 combo: +0.15 (extra)
# PD-L1 trials: +0.1
```

---

## 🎯 **COMPOUND RANKING FORMULA**

### **Enhanced Trial Scoring**

```
score = (0.5 × eligibility) + (0.3 × mechanism_fit) + (0.2 × ayesha_relevance)
```

Where:
- **α = 0.5** (eligibility still matters)
- **β = 0.3** (mechanism fit)
- **γ = 0.2** (Ayesha-specific relevance)

---

## 📋 **OPTIMAL TRIALS FOR AYESHA**

| Priority | Trial Type | Why It Fits Ayesha |
|----------|-----------|-------------------|
| **P0** | PARP + ATR inhibitor combos | BER deficient + TP53 mutant = synthetic lethality |
| **P0** | Olaparib/Niraparib maintenance | Stage IVB HGSOC, PARP eligible |
| **P1** | Pembrolizumab + chemo | PD-L1 CPS 10 (positive) |
| **P1** | DDR-deficient basket trials | MBD4 = DDR gene |
| **P2** | TP53 mutation trials | p53 mutant-type |
| **P2** | Platinum + bevacizumab | Standard SOC with VEGF |
| **P3** | PDGFRA TKI trials | If VUS resolves to pathogenic |

---

## 📋 **IMPLEMENTATION PLAN**

### **Files to Modify:**

1. **Trial extraction script** → Add 8 targeted searches
2. **mechanism_fit_ranker.py** → Add patient-specific relevance scoring
3. **trial_moa_vectors.json** → Add `ayesha_relevance` field
4. **_get_fallback_ovarian_trials()** → Use enhanced ranking

### **Steps:**

1. ✅ Read and understand strategy (DONE)
2. ⏳ Implement 8 targeted searches
3. ⏳ Add patient-specific relevance scoring to tagging
4. ⏳ Implement compound ranking formula
5. ⏳ Test with Ayesha's profile

---

## ✅ **STATUS**

**Current State:** Strategy received from manager  
**Next Action:** Implement targeted searches and enhanced ranking  
**Question:** Should I coordinate implementation now?
